Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
Diagnostics | Free Full-Text | Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers
A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial) | SpringerLink
Olaparib in Metastatic Pancreatic Cancer
ASCO GI 2021: Results From the Phase 3 POLO Trial
POLO trial for advanced pancreatic cancer: a | EurekAlert!
LYNPARZA® (olaparib) Efficacy for Metastatic Pancreatic Cancer
Olaparib maintenance therapy improves PFS in BRCA-mutated metastatic pancreatic cancer | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Dr. Antonio Calles 🫁🚭 on Twitter: "LBA4 POLO trial: olaparib maintenance in germline BRCA mutant pancreatic adenocarcinoma. Nice data but... PFS as primary endpoint comparing active drug vs no treatment is not
FORCE Blog | New PARP Inhibitor Approval for Pancreatic Cancer
Dr Amol Akhade on Twitter: "19 vs 19.2 . POLO . Metastatic pancrease ca. Once again Placebo arm has longer OS than Olaparib. I really appreciate the positive spin off by medical
HCP's Thoughts On Pancreatic Cancer | Knowledge | CREATION.co
Maintenance rucaparib shows benefit in broader group of patients with pancreatic cancer
New Homologous Recombination Deficiency Findings in Pancreatic Cancer Alter Treatment Focus
Sotorasib in KRAS p.G12C-mutated Pancreatic Cancer
Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post
Olaparib for Pancreatic Cancer with BRCA Mutations - NCI
Olaparib maintenance therapy improves PFS in BRCA-mutated metastatic pancreatic cancer | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
ASCO GI 2021: Results From the Phase 3 POLO Trial
Pancreatic Cancer - ASCO GI 2021 Highlights - Module - 2021 ASCO GI - Oncology - Clinical Care Options
